If approved on schedule, US patients could access it in early-to-mid 2027
The patient group consulted by CADTH emphasized that the health issues faced by patients with SPIGFD run deeper than just height and affect their entire lives
These weight-loss drugs work by mimicking natural hormones that regulate appetite, insulin secretion, and glucose levels
While the loss of GSH does not cause liver failure, it decreases lipogenic enzyme expression, circulating triglyceride levels, and fat stores
This FDA-approved medication is at the forefront of weight loss strategies, helping patients achieve significant and lasting results
More Than A Medical Issue: The Ethical Debate Theres a genuine ethical question underneath all of this: where is the line between treatment and enhancement